Company
Product List
Offer to buy
Offer to sell
登入
加入會員
求助
Languages
English
繁體中文
簡體中文
Changchun Changsheng Life Sciences Ltd.
回首頁
公司簡介
產品櫥窗
影音視聽
寄出詢問函
聯絡我們
Recommended Results
Clinical Rabies Vaccine For Human Use
產品分類 :
化學->化學用品->aspalthic products
View Larger Picture
View Larger Picture
View Larger Picture
產品規格
Model No:
0.5ml /syringe
Country
CN
Minimum Order
5000
Payment Term
L/C,T/T
產品描述
<p class="MsoNormal">
<span>
<p class="MsoNormal">
Rabies vaccine is a freeze-dried preparation made from the inactivated rabies fixed virus. The virus grows in Vero cells. After cultivation, harvest and concentration, the virus suspension is inactivated, purified and then lyophilized to make the vaccine after the addition of a suitable stabilizer. It is used to prevent rabies.
</p>
<br />
</span>
</p>
<p class="MsoNormal">
<span>If a person is bitten or scratched by a rabid dog or other rabid animals, regardless of age or sex, the wounds shall be cleaned immediately (flush the wounds repeatedly with clean water or soup water, followed by applying iodine tincture or ethanol for several times), and the exposed person shall be inoculated with the vaccine according to the post-exposure schedule as soon as possible. The person at risk of contacting rabies virus (such as veterinarians, animal breeders, forestry workers, workers in slaughterhouse and staffs in rabies laboratory) shall be immunized following the pre-exposure treatment schedule.</span>
</p>
<p class="MsoNormal">
<span><br />
</span>
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
<span>[</span>Function and use<span>]</span>
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
The preparation can induce immunity against rabies virus in recipients following immunization. It is used to prevent rabies in human.
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
<br />
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
<span>[</span>Specifications<span>]</span>
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
0.5 ml of reconstituted vaccine per container. 0.5 ml per single human dose. The potency of the vaccine shall be not less than 2.5 IU.
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
<br />
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
<p class="MsoNormal">
[Diluent of Vaccine]
</p>
<p class="MsoNormal">
Sterile water for injection used as the diluent shall comply with the specifications set forth in Volume II of the Chinese Pharmacopoeia.
</p>
<p class="MsoNormal">
[Control tests on final product]
</p>
<p class="MsoNormal">
Other than the determination of the moisture content,the enclosed sterile water for injection shall be added into the final product as the stated value,and the reconstitude product shall be subjected to the following tests.
</p>
<p class="MsoNormal">
Identity test
</p>
<p class="MsoNormal">
Rabies viral antigen in the tese sample shall be demonstrated with ELISA.
</p>
<p class="MsoNormal">
Apperance
</p>
<p class="MsoNormal">
The product looks like a white crisp cake.After reconstitution,it shall turn into transparent liquid free from foreign matters.
</p>
<p class="MsoNormal">
Chemical tests
</p>
<p class="MsoNormal">
pH
</p>
<p class="MsoNormal">
The pH shall be 7. 2-8. 0 (Appendix V A).
</p>
<p class="MsoNormal">
Moisture content
</p>
<p class="MsoNormal">
The content of residual moisture shall be not more than 3. 0% (Appendix XII D).
</p>
<p class="MsoNormal">
Potency test
</p>
<p class="MsoNormal">
The potency of the vaccine shall be not less than 2. 5 IU/dose (Appendix XI A).
</p>
<p class="MsoNormal">
Thermostability test
</p>
<p class="MsoNormal">
Before release each lot of vaccine shall be subjected to thermostability test. The test sample is exposed at 37℃for 28 days for the determination of potency (Section 3. 4. 4) . The test vaccine which passed the thermostability test is considered satisfactory in potency test.
</p>
<p class="MsoNormal">
Test for residual bovine serum albumin
</p>
<p class="MsoNormal">
The content of residual bovine serum albumin shall be not more than 50 µg/does (Appendix XIII I).
</p>
<p class="MsoNormal">
Test for the content of residual antibiotics
</p>
<p class="MsoNormal">
Test for the content of residual antibiotics shall be carried out if antibiotics have been added during the production. The residual antibiotic content shall be not more than 50 ng/dose determined by ELISA.
</p>
<p class="MsoNormal">
Test for residual DNA of Vero cells
</p>
<p class="MsoNormal">
The residual DNA of Vero cells shall be not more than 100 pg/dose (Appendix IX B, method l).
</p>
<p class="MsoNormal">
Test for residual protein of Vero cells
</p>
<p class="MsoNormal">
The residual protein of Vero cells shall be not more than 4 µg/dose by ELISA.
</p>
<p class="MsoNormal">
Sterility test
</p>
<p class="MsoNormal">
It complies with the test for sterility (Appendix XII A) .
</p>
<p class="MsoNormal">
Test for abnormal
</p>
<p class="MsoNormal">
It complies with the test (Appendix XII F).
</p>
<p class="MsoNormal">
Test for bacterial endotoxin
</p>
<p class="MsoNormal">
The content of bacterial endotoxin shall be not more than 50EU/does.(Appendix XII E, gel-clot limit test).
</p>
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
<span>[</span>Feature<span>]</span>
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
1. High potency at least 4.0IU/dose
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
2. Perfect stability, 3-years shelf life
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
3. Fine purification above 99%.
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
4. No serious adverse reaction.
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
5. Medium can be controlled effectively.
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
<img src="http://i.bosscdn.com/product/e6/40/1a/52042c3373d7e6bc01c1975301.png@watermark=2&color=I0ZGRkZGRg%3D%3D&type=ZHJvaWRzYW5zZmFsbGJhY2s%3D&size=22&p=5&t=80&text=Y3MtdmFjY2luZS5ib3NzZ29vLmNvbQ%3D%3D" title="rabies" alt="rabies" />
</p>
<p>
<br />
</p>ccls-vaccine.com
其他類似產品
PFS Varicella Vaccine, Live
Vaccinate Influenza Vaccine For Human
Rabies vaccine for 3 years
Preventing Chickenpox Vaccine (Freeze-Dried)
[ Back Products Catalog ]
Commerce 會員:
請登入您的 帳號 跟 密碼, 系統將自動為您填入您的相關基本資料!
帳號:
密碼:
記住我的帳號
填寫下列表格並寄送詢問函.所有的詢問信函將會自動寄發給你想聯絡的公司
主旨
內容
﹙ 請勿輸入公司名稱、Email、電話、傳真、網址 ﹚
公司簡介:
*
公司名稱
*
E-mail
*
國家
Please Select Your Country
United States
Afghanistan
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaidjan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Cook Islands
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
East Timor
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands
Faroe Islands
Fiji
Finland
Former Czechoslovakia
Former USSR
France
France (European Territory)
French Guyana
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Great Britain
Greece
Greenland
Grenada
Guadeloupe (French)
Guam (USA)
Guatemala
Guinea
Guinea Bissau
Guyana
Haiti
Heard and McDonald Islands
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique (French)
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldavia
Monaco
Mongolia
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
Neutral Zone
New Caledonia (French)
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Island
Poland
Polynesia (French)
Portugal
Puerto Rico
Qatar
Reunion (French)
Romania
Russian Federation
Rwanda
S. Georgia & S. Sandwich Isls.
Saint Helena
Saint Kitts & Nevis Anguilla
Saint Lucia
Saint Pierre and Miquelon
Saint Tome (Sao Tome) and Principe
Saint Vincent & Grenadines
Samoa
San Marino
Saudi Arabia
Senegal
Seychelles
Sierra Leone
Singapore
Slovak Republic
Slovenia
Solomon Islands
Somalia
South Africa
South Korea
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen Islands
Swaziland
Sweden
Switzerland
Syria
Tajikistan
Taiwan
Tanzania
Thailand
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Uzbekistan
Vanuatu
Vatican City State
Venezuela
Vietnam
Virgin Islands (British)
Virgin Islands (USA)
Wallis and Futuna Islands
Western Sahara
Yemen
Yugoslavia
Zaire
Zambia
Zimbabwe
*
聯絡人
網址
*
電話
-
-
傳真
-
-
*
郵遞區號
*
城市
*
街道地址
*
企業形態
批發商
出口商
進口商
製造商
大盤商
零售商
代理商
Retrofitter
使用者
其他, 請詳細說明:
*
安全密碼
請輸入所顯示的安全密碼
網站導覽 l
隱私權政策 l
服務團隊 l
合作提案 l
聯絡我們 l
幫幫我 l
廣告刊登 l
B2B商業夥伴
.